Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Postexposure rabies prophylaxis completed in 1 week: preliminary study.

Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N, Lohsoonthorn V, Khawplod P, Tantawichien T.

Clin Infect Dis. 2010 Jan 1;50(1):56-60. doi: 10.1086/649211.

PMID:
19995217
3.

Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.

Wongsaroj P, Udomchaisakul P, Tepsumethanon S, Khawplod P, Tantawichien T.

Vaccine. 2013 Mar 25;31(13):1748-51. doi: 10.1016/j.vaccine.2013.01.035. Epub 2013 Jan 29.

PMID:
23370149
4.

Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.

Tantawichien T, Sibunruang S, Tantawichien T, Angsanakul J, Benjavongkulchai M, Limsuwan K, Udomchaisakul P, Khomvilai S, Sitprija V.

Expert Rev Vaccines. 2014 Dec;13(12):1593-601. doi: 10.1586/14760584.2014.971764. Epub 2014 Oct 15.

PMID:
25315021
5.

Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.

Madhusudana SN, Sanjay TV, Mahendra BJ, Suja MS.

Int J Infect Dis. 2004 May;8(3):175-9.

6.

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.

Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C.

Bull World Health Organ. 2000;78(5):693-8.

7.

A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).

Ashwathnarayana DH, Madhusudana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HH, Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, Shamanna M.

Vaccine. 2009 Dec 10;28(1):148-51. doi: 10.1016/j.vaccine.2009.09.090. Epub 2009 Oct 8. Erratum in: Vaccine. 2010 Mar 16;28(13):2575.

PMID:
19818720
8.

Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.

Kerdpanich P, Chanthavanich P, De Los Reyes MR, Lim J, Yu D, Ama MC, Mojares Z, Casula D, Arora AK, Pellegrini M.

PLoS Negl Trop Dis. 2018 Jun 6;12(6):e0006340. doi: 10.1371/journal.pntd.0006340. eCollection 2018 Jun.

9.

Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML.

Madhusudana SN, Sanjay TV, Mahendra BJ, Sudarshan MK, Narayana DH, Giri A, Muhamuda K, Ravi V, Vakil HB, Malerczyk C.

Hum Vaccin. 2006 Sep-Oct;2(5):200-4.

PMID:
17035734
10.

Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine.

Lang J, Attanath P, Quiambao B, Singhasivanon V, Chanthavanich P, Montalban C, Lutsch C, Pepin-Covatta S, Le Mener V, Miranda M, Sabchareon A.

Acta Trop. 1998 Jul 30;70(3):317-33.

PMID:
9777717
11.

Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimen.

Khawplod P, Glueck R, Wilde H, Tantawichien T, Chomchey P, Thipkong P, Benjavongkulchai M, Sumboonanondha A, Prakongsri S, Siakasem A, et al.

Clin Infect Dis. 1995 Mar;20(3):646-51.

PMID:
7756490
12.

Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial).

Jaiiaroensup W, Lang J, Thipkong P, Wimalaratne O, Samranwataya P, Saikasem A, Chareonwai S, Yenmuang W, Prakongsri S, Sitprija V, Wilde H.

Vaccine. 1998 Oct;16(16):1559-62.

PMID:
9711804
13.
14.

Neutralizing antibody response after intradermal rabies vaccination in hemodialysis patients.

Tanisaro T, Tantawichien T, Tiranathanagul K, Susantitaphong P, Chirananthavat T, Praditpornsilpa K, Sitprija V, Eiam-Ong S.

Vaccine. 2010 Mar 11;28(12):2385-7. doi: 10.1016/j.vaccine.2010.01.003. Epub 2010 Jan 17.

PMID:
20085837
17.

Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.

Tantawichien T, Benjavongkulchai M, Limsuwan K, Khawplod P, Kaewchompoo W, Chomchey P, Sitprija V.

Clin Infect Dis. 1999 May;28(5):1100-3.

PMID:
10452642
18.

Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine.

Sampath G, Madhusudana SN, Sudarshan MK, Ashwathnarayana DH, Mahendra BJ, Ullas TP, Mohan K, Madhusudhan SK, Ravish HS.

Vaccine. 2010 May 28;28(24):4086-90. doi: 10.1016/j.vaccine.2010.03.064. Epub 2010 Apr 18.

PMID:
20403351
19.

An immunogenicity study of a newly introduced purified Vero cell rabies vaccine (Abhayrab) manufactured in India.

Sampath G, Reddy SV, Rao ML, Rao YU, Palaniappan C.

Vaccine. 2005 Jan 4;23(7):897-900.

PMID:
15603890
20.

Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine.

Jones RL, Froeschle JE, Atmar RL, Matthews JS, Sanders R, Pardalos J, Moeller L, Chin JE, Famula M, Briggs DJ, Lang J.

Vaccine. 2001 Sep 14;19(32):4635-43.

PMID:
11535311

Supplemental Content

Support Center